Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
By
MedTech Outlook | Wednesday, January 31, 2024
Regulations on medical devices are subject to continuous modification, so businesses must be ready to adjust. This article describes strategies companies may use to become more adaptable to prosper in an environment of these constantly increasing shifts in innovation and legislation.
Fremont, CA: The regulatory landscape has been shaken by the emergence of concerns about artificial intelligence (AI), telemedicine, and data privacy. This pattern offers opportunities as well as challenges. Businesses that can swiftly adjust to changes in regulations might exceed their rivals. Here are some strategies on how companies might adapt to changing MedTech laws.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Transparency
The first step to surviving in the face of regulatory changes about medical devices is ensuring visibility. If businesses are unaware of how new rules and regulations may affect their ongoing operations, they cannot comply with them.
Transparency needs are frequently greatest in supply chain management. Remarkably, just 45% of brands are visible to consumers past their first-tier suppliers. Medical device makers must improve data exchange with partners via digital supply chain twins and real-time tracking tools to counteract that tendency.
The gathering and organizing of data has a significant impact on maximizing transparency. Cloud computing enables businesses to consolidate pertinent real-time data from Internet of Things (IoT) devices into a unified point of view. This digitalization will streamline regulatory compliance by making obtaining an exhaustive summary of activities more straightforward.
Automated Compliance
Manual compliance is insufficient because medical device standards change too often, even with early modifications. Therefore, MedTech firms should automate their compliance operations whenever possible to facilitate quicker answers.
One typical problem to solve is documentation. Most employees input data for one to three hours each day, and 73% also spend that time looking for particular information. Compliance requires these time-consuming, repetitive, data-intensive procedures, but executing them manually would take too long. Automating them with AI and robotic process automation (RPA) dramatically reduces the manual labour of compliance.
Additional automation of the compliance process is possible with more recent AI systems. Certain technologies can search legal papers for pertinent rules, compare those requirements to the present workflows, and identify non-compliance areas. These prompt, precise audits enable quicker modifications in response to changing laws.
R&D
Another area that may be reduced to allow for compliance agility is research and development (R&D). Many other authorities adopt similar views, with the FDA providing only broad guidelines on complying with its rules. Device makers are then forced to invest time in research and development to determine how to comply with new laws, which frequently results in delays and bottlenecks.
Higher productivity in R&D is primarily dependent on automation and AI. Production line inefficiencies may be identified with digital twins. Clinical trial data input may be automated with AI-powered RPA to minimize mistakes and time. The same is true for AI, which can identify the best demographics for these studies and automatically contact them.
While some laws demand minor changes, others may necessitate whole product redesigns. Either way, an excessively manual, rigid R&D approach will add unnecessary time to the adoption process.
More in News
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
